Veradigm Inc. (MDRX) has a MoatMap StockRank of 73/100 based on Quality (42/100), Value (51/100), and Momentum (64/100) factor scores. The current signal is BUY. Veradigm is a healthcare technology company that has recently faced severe financial reporting and delisting challenges. This turnaround/broken story fails our Terry Smith and Warren Buffett quality filters, which demand clean governance and predictable operations.
Veradigm Inc. provides healthcare technology solutions, including electronic health records (EHR), practice management, and payer/life sciences services. This established player in healthcare IT offers a broad suite of software and analytics solutions that integrate across the healthcare ecosystem. The company serves a diverse client base of physicians, hospitals, and pharmaceutical companies, facilitating interoperability and data-driven insights.
| Price | $5.10 |
| Market Cap | $517M |
| P/E (Forward) | 15.54 |
| Price/Book | 0.64 |
| Return on Equity | -31.0% |
| Return on Invested Capital | -4.5% |
| Debt/Equity | 18.59 |
| Gross Margin | 50.8% |
| Operating Margin | 16.6% |
| Revenue Growth | 5.0% |
| Free Cash Flow | $-8M |
Veradigm Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).